Medicare Enrolled
Dr. Fouad Albana
Nephrology · Holmdel, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Albana from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Albana?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Albana
Dr. Fouad Albana is a nephrology specialist in Holmdel, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Albana performed 1,574 Medicare services across 608 unique beneficiaries.
Between the years covered by Open Payments, Dr. Albana received a total of $5,578 from 30 pharmaceutical and/or device companies across 154 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. Payments are distributed across multiple categories and often reflect legitimate professional engagement with the medical industry. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Albana is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 48% volume in NJ
$5,578 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,574
Medicare services
Top 48% in NJ for nephrology
608
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~79 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
391 | $37 | $150 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
387 | $65 | $176 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
151 | $88 | $240 |
| Home visit, established patient, low complexity A physician visits an existing patient at their residence to provide care involving a low level of medical decision making. The visit lasts at least 30 minutes. |
118 | $55 | $430 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
80 | $58 | $220 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
68 | $87 | $178 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
62 | $96 | $249 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
59 | $52 | $100 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
55 | $8 | $35 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
41 | $64 | $220 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
39 | $68 | $240 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
25 | $40 | $75 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
21 | $25 | $87 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
20 | $17 | $65 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
17 | $137 | $230 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
15 | $136 | $280 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
13 | $9 | $100 |
| Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 12 | $56 | $175 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,578
Total received (2018-2024)
Avg $797/year across 7 years
Top 12% in NJ for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
154
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Other
Charitable contributions, space rental, and other categories
$3,070 (55.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,322 (41.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$186 (3.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,206
2023
$637
2022
$571
2021
$477
2020
$298
2019
$311
2018
$77
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Johnson & Johnson Health Care Systems Inc.
$3,070
Bayer Healthcare Pharmaceuticals Inc.
$85
DePuy Synthes Sales Inc.
$20
Novartis Pharmaceuticals Corporation
$19
AstraZeneca Pharmaceuticals LP
$14
Top 3 companies account for 99.0% of 2024 payments
All-time payments by company (2018-2024) ›
Johnson & Johnson Health Care Systems Inc.
$3,070
AstraZeneca Pharmaceuticals LP
$487
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$329
Otsuka America Pharmaceutical, Inc.
$214
Bayer Healthcare Pharmaceuticals Inc.
$212
Merck Sharp & Dohme LLC
$188
Bayer HealthCare Pharmaceuticals Inc.
$116
Mallinckrodt Hospital Products Inc.
$107
Indivior Inc.
$105
OPKO Pharmaceuticals, LLC
$100
Janssen Pharmaceuticals, Inc
$78
Amgen Inc.
$69
Novartis Pharmaceuticals Corporation
$65
Avanir Pharmaceuticals, Inc.
$55
Novo Nordisk Inc
$47
Ascensia Diabetes Care US Inc.
$42
Abbott Laboratories
$39
DePuy Synthes Sales Inc.
$38
Lilly USA, LLC
$33
Merck Sharp & Dohme Corporation
$28
Horizon Therapeutics plc
$28
Vifor Pharma, Inc.
$19
Daiichi Sankyo Inc.
$15
Otsuka Pharmaceutical Development & Commercialization, Inc.
$15
E.R. Squibb & Sons, L.L.C.
$15
Alfasigma USA, Inc.
$15
Ultragenyx Pharmaceutical Inc.
$14
Fresenius USA Marketing, Inc.
$14
Endo Pharmaceuticals Inc.
$13
Relypsa, Inc.
$12
Top 3 companies account for 69.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · BREZTRI · BRILINTA · BYDUREON · Cryvista · ELIQUIS · ENTRESTO · FARXIGA · FreeStyle Libre 2 · INJECTAFER · JARDIANCE · JYNARQUE · KRYSTEXXA · Kerendia · LOKELMA · MONOVISC · NASCOBAL · NUEDEXTA · ORTHOVISC · Otezla · Ozempic · Parsabiv · RAYALDEE · Rayaldee · Repatha · Rybelsus · STEGLATRO · SUBLOCADE · TRULANCE · VERQUVO · Velphoro · Veltassa · XARELTO · XIFAXAN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Payments are distributed across multiple categories with no single dominant type.
Geographic Context
Nephrologists within 10 mi
238
Per 100K population
37.0
County median income
$122,727
Nearest hospital
BAYSHORE MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Albana is a clinical cardiology specialist, with moderate Medicare volume, with mixed engagement industry engagement in the top 12% of NJ peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Albana experienced with hospital follow-up visit, low complexity?
Based on Medicare claims data, Dr. Albana performed 391 hospital follow-up visit, low complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Albana receive payments from pharmaceutical companies?
Yes. Dr. Albana received a total of $5,578 from 30 companies across 154 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Albana's costs compare to other nephrologists in Holmdel?
Dr. Albana's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Albana) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Nephrology
Common procedures, typical costs, and what industry payments mean in nephrology.
Same specialty & city
Nephrologists in Holmdel
Browse nephrologists in Holmdel ranked by procedure volume and transparency data.
Highest volume
Top Nephrologists in NJ
Nephrologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nephrologists in NJ
Which NJ nephrologists receive the most from drug and device companies.
By company
Johnson & Johnson Health Care Systems Inc. Payments to Doctors
See all physicians who received payments from Johnson & Johnson Health Care Systems Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology